valine and Venous Thrombosis

valine has been researched along with Venous Thrombosis in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Duan, J; Ji, X; Jiang, H; Li, M; Liu, L; Meng, R; Wei, H; Wu, Y; Xiao, X; Zhou, C; Zhou, Y1
Barosi, G; Bergamaschi, G; Carolei, A; Catarsi, P; Poletto, V; Primignani, M; Rosti, V; Spolverini, A; Vannucchi, AM; Villani, L1
Ariƫns, RA; Bertina, RM; Grant, PJ; Komanasin, N; Poort, SR; Rosendaal, FR; Van Hylckama Vlieg, A1
Francis, CW1
Rosendaal, FR; Vossen, CY1
Anderson, JL; Doucette, SP; Gagnon, F; Scarvelis, DK; Wells, PS1
Anderson, JL; Carson, N; Doucette, SP; Grimwood, RL; Rodger, MA; Wells, PS1
Amitrano, L; Brancaccio, V; Colaizzo, D; Grandone, E; Guardascione, MA; Margaglione, M; Scenna, G; Tiscia, GL1

Reviews

2 review(s) available for valine and Venous Thrombosis

ArticleYear
Factor XIII polymorphisms and venous thromboembolism.
    Archives of pathology & laboratory medicine, 2002, Volume: 126, Issue:11

    Topics: Blood Coagulation Tests; Enzyme-Linked Immunosorbent Assay; Factor XIII; Fibrinolysis; Humans; Polymorphism, Genetic; Risk Factors; Thromboembolism; Thrombophilia; Valine; Venous Thrombosis

2002
Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    American journal of epidemiology, 2006, Jul-15, Volume: 164, Issue:2

    Topics: Amino Acid Substitution; Factor XIII; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Leucine; Point Mutation; Polymorphism, Genetic; Risk Factors; Thromboembolism; Valine; Venous Thrombosis

2006

Other Studies

6 other study(ies) available for valine and Venous Thrombosis

ArticleYear
Potential role of plasma branched-chain amino acids in the differential diagnosis of acute cerebral venous thrombosis.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2023, Volume: 43, Issue:9

    Topics: Amino Acids, Branched-Chain; Biomarkers; Diagnosis, Differential; Humans; Isoleucine; Leucine; Valine; Venous Thrombosis

2023
JAK2 46/1 haplotype predisposes to splanchnic vein thrombosis-associated BCR-ABL negative classic myeloproliferative neoplasms.
    Leukemia research, 2012, Volume: 36, Issue:1

    Topics: Bone Marrow Neoplasms; Case-Control Studies; Fusion Proteins, bcr-abl; Gene Frequency; Genetic Predisposition to Disease; Haplotypes; Humans; Janus Kinase 2; Mesenteric Vascular Occlusion; Mesenteric Veins; Mutation; Myeloproliferative Disorders; Phenylalanine; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Splanchnic Circulation; Valine; Venous Thrombosis

2012
Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    British journal of haematology, 2002, Volume: 119, Issue:1

    Topics: Adolescent; Adult; Aged; Case-Control Studies; Factor XIII; Factor XIIIa; Female; Genotype; Humans; Leucine; Male; Middle Aged; Polymorphism, Genetic; Risk Factors; Valine; Venous Thrombosis

2002
The protective effect of the factor XIII Val34Leu mutation on the risk of deep venous thrombosis is dependent on the fibrinogen level.
    Journal of thrombosis and haemostasis : JTH, 2005, Volume: 3, Issue:5

    Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Case-Control Studies; Cross-Linking Reagents; Factor XIII; Female; Fibrinogen; Gene Frequency; Heterozygote; Homozygote; Humans; Leucine; Male; Middle Aged; Mutation; Odds Ratio; Risk; Valine; Venous Thrombosis

2005
The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2006, Volume: 17, Issue:7

    Topics: Amino Acid Substitution; Case-Control Studies; Factor XIII; Female; Genetic Predisposition to Disease; Genotype; Humans; Leucine; Male; Middle Aged; Odds Ratio; Polymorphism, Genetic; Risk Assessment; Thromboembolism; Valine; Venous Thrombosis; White People

2006
The JAK2 V617F mutation frequently occurs in patients with portal and mesenteric venous thrombosis.
    Journal of thrombosis and haemostasis : JTH, 2007, Volume: 5, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Child; Cohort Studies; Female; Follow-Up Studies; Gene Frequency; Genetic Predisposition to Disease; Humans; Italy; Janus Kinase 2; Male; Mesenteric Vascular Occlusion; Mesenteric Veins; Middle Aged; Mutation; Myeloproliferative Disorders; Odds Ratio; Phenylalanine; Portal Vein; Risk Factors; Time Factors; Valine; Venous Thrombosis; Von Hippel-Lindau Tumor Suppressor Protein

2007